DAWN

DAWN Operating Cash Flow (Statement)

-$103.76MTTM · USD

Period ending:

DAWN FY Cash from OperationsUSD
DAWN FY Cash from Operations2019-12-31: -$4.52M2020-12-31: -$13.49M2021-12-31: -$48.54M2022-12-31: -$109.87M2023-12-31: -$146.85M2024-12-31: -$78.11M2025-12-31: -$103.76M$0.00-$146.85M
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DAWN operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Day One Biopharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-103,757,000
-78,113,000
-146,853,000
-109,874,000
-48,539,000
-13,489,000
-4,515,000

Compare operating cash flow (statement)

All DAWN financial metrics · DAWN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.